Preparation and antitumor study of camptothecin nanocrystals

International Journal of Pharmaceutics

Volumn 415, Issue 1-2, 2011, Pages 293-300

  Zhang, Hua ^a   Hollis, Christin P ^b   Zhang, Qiang ^a   Li, Tonglei ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b University of Kentucky   (United States)

Author keywords

Antitumor efficacy; Camptothecin; MCF 7; Nanocrystals; Nanosuspension

Indexed keywords

CAMPTOTHECIN; NANOCRYSTAL;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG POTENCY; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; DRUG TUMOR LEVEL; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CELL LINE, TUMOR; CELL SURVIVAL; DRUG COMPOUNDING; DRUG STABILITY; DRUG STORAGE; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; SOLUBILITY; SONICATION; SURFACE PROPERTIES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960153105     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.05.075     Document Type: Article

References (38)

1. R. Barreio-Iglesias, L. Bromberg, M. Temchenko, T.A. Hatton, A. Concheiro, and C. Alvarez-Lorenzo Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers J. Control. Release 97 2004 537 549 (Pubitemid 38802955)
2. T.G. Burke, and Z. Mi Preferential binding of the carboxylate form of camptothecin by human serum albumin Anal. Biochem. 212 1993 285 287 (Pubitemid 23219487)
3. R. Cortesi, E. Esposito, A. Maietti, E. Menegatti, and C. Nastruzzi Formulation study for the antitumor drug camptothecin: liposomes, micellar solution, and a microemulusion Int. J. Pharm. 159 1997 95 103 (Pubitemid 28062814)
4. A. Diaz-Moscoso, D. Vercauteren, J. Rejman, J.M. Benito, C.O. Mellet, S.C. De Smedt, and J.M.G. Fernandez Insights in cellular uptake mechanisms of pDNA-polycationic amphiphilic cyclodextrin nanoparticles (CDplexes) J. Control. Release 143 2010 318 325
5. H.L. Fan, J. Huang, Y.P. Li, J.H. Yu, and J.H. Chen Fabrication of reduction-degradable micelle based on disulfide-linked graft copolymer-camptothecin conjugate for enhancing solubility and stability of camptothecin Polymer 51 2010 5107 5114
6. J. Fassberg, and V.J. Stella A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogus J. Pharm. Sci. 81 1992 676 684 (Pubitemid 23006796)
7. A. Gabr, A. Kuin, M. Aalders, H. El-Gawly, and L.A. Smets Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH Cancer Res. 57 1997 4811 4816 (Pubitemid 27468988)
8. S.E.A. Gratton, P.A. Ropp, P.D. Pohlhaus, J.C. Luff, V.J. Madden, M.E. Napier, and J.M. Desimone The effect of particles design on cellular internalization pathways Proc. Natl. Acad. Sci. U.S.A. 105 2008 11613 11618
9. Z. Guo, M. Zhang, H. Li, J. Wang, and E. Kougoulos Effect of ultrasound on anti-solvent crystallization process J. Cryst. Growth 273 2005 555 563
10. S.L. Hem The effect of ultrasonic vibrations on crystallization processes Ultrasonics 5 1967 202 207
11. R.P. Hertzberg, M.J. Caranfa, and S.M. Hecht On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex Biochemistry 28 1989 4629 4638 (Pubitemid 19151036)
12. S. Hobbs, W.L. Monsky, F. Yuan, W.G. Roberts, L. Griffith, V.P. Torchilin, and R.K. Jain Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc. Natl. Acad. Sci. U.S.A. 95 1998 4607 4612 (Pubitemid 28207960)
13. M. Hong, S. Zhu, Y. Jiang, G.T. Tang, C. Sun, C. Fang, B. Shi, and Y. Pei Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferring-PEG-nanoparticles J. Control. Release 141 2010 22 29
14. J.S. Kaerger, and R. Price Processing of spherical crystalline particles via a novel solution atomization and crystallization by sonication (SAXS) technique Pharm. Res. 21 2004 372 381 (Pubitemid 38221985)
15. K. Kawano, M. Watanabe, T. Yamamoto, M. Yokoyama, P. Opanasopit, T. Okano, and Y. Maitani Enhance antitumor effect of camptothecin loaded in long-circulating polymeric micelles J. Control. Release 112 2006 329 332
16. R. Kunii, H. Onishi, and Y. Machida Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin Eur. J. Pharm. Biopharm. 67 2007 9 17 (Pubitemid 46991341)
17. F. Liu, J. Park, Y. Zhang, C. Conwell, Y. Liu, S.R. Bathula, and L. Huang Targeted cancer therapy with novel high drug-loading nanocrystals J. Pharm. Sci. 99 2010 3542 3551
18. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzyme Regul. 41 2001 189 207
19. L.D. Mayer, R. Krishna, M. Webb, and M. Bally Designing liposomal anticancer drug formulations for specific therapeutic applications J. Liposome Res. 10 2000 99 115
20. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 2003 113 120 (Pubitemid 36184748)
21. H. Miura, H. Onishi, M. Sasatsu, and Y. Machida Antitumor characteristics of methoxypolyethylene glycol-poly(dl-lactic acid) nanoparticles containing camptothecin J. Control. Release 97 2004 101 113 (Pubitemid 38624513)
22. P. Opanasopit, M. Yokoyama, M. Watanabe, K. Kawano, Y. Maitani, and T. Okano Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting Pharm. Res. 21 2004 2001 2008 (Pubitemid 40941219)
23. M. Potmesil Camptothecin: from bench research to hospital wards Cancer Res. 54 1994 1431 1439 (Pubitemid 24106402)
24. B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796 (Pubitemid 39242830)
25. A.M. Saetern, M. Brandl, W.H. Bakkelund, and B. Sveinbjornsson Cytotoxic effects of different camptothecin formulations on human colon carcinoma in vitro Anticancer Drugs 15 2004 899 906 (Pubitemid 39482931)
26. J. Rejman, V. Oberle, I.S. Zuhorn, and D. Hoekstra Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis Biochem. J. 377 2004 156 169
27. B. Selvi, S. Patel, and M. Savva Physicochemical characterization and membrane binding properties of camptothecin J. Pharm. Sci. 97 2008 4379 4390
28. V.P. Torchilin Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 24 2007 1 16 (Pubitemid 44902565)
29. B. Van Eerdenbrugh, G. Van den Mooter, and P. Augustijns Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products Int. J. Pharm. 364 2008 64 75
30. V.J. Venditto, and E.E. Simanek Cancer therapies utilizing the camptothecin: a review of in vivo literature Mol. Pharm. 7 2010 307 314
31. M.E. Wall, M.C. Wani, C.E. Cooke, K.H. Palmer, A.T. McPhail, and G.A. Sim Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata J. Am. Chem. Soc. 88 1966 3888 3890
32. L.H. Wang, K.G. Rothberg, and R.G. Anderson Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation J. Cell Biol. 123 1993 1107 1117 (Pubitemid 23352421)
33. D. Yu, P. Peng, S.S. Dharap, Y. Wang, M. Mehlig, P. Chandna, H. Zhao, D. Filpula, K. Yang, V. Borowski, G. Borchard, Z.H. Zhang, and T. Minko Antitumor activity of poly(ethylene glycon)-camptothecin conjugate: the inhibition of tumor growth in vivo J. Control. Release 110 2005 90 102 (Pubitemid 41713934)
34. S. Yang, L. Lu, Y. Cai, J. Zhu, B. Liang, and C. Yang Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain J. Control. Release 59 1999 299 307 (Pubitemid 29238174)
35. X.H. Zhao, Y.G. Zu, Q.Y. Li, M.X. Wang, B.S. Zu, X.N. Zhang, R. Jiang, and C.L. Zu Preparation and characterization of camptothecin powder micronized by a supercritical antisolvent (SAS) process J. Supercrit. Fluids 51 2010 412 419
36. Y. Zhao, H. Hua, M. Chang, W. Liu, Y. Zhao, and H. Liu Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions Int. J. Pharm. 392 2010 64 71
37. L. Zhou, X. Li, X. Chen, Z. Li, X. Liu, S. Zhou, Q. Zhong, T. Yi, Y. Wei, X. Zhao, and Z. Qian In vivo antitumor and antimetastatic activities of camptothecin encapsulated with N-trimethyl chitosan in a preclinical mouse model of liver cancer Cancer Lett. 297 2010 56 64
38. I.S. Zuhorn, R. Kalicharan, and D. Hoekstra Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis J. Biol. Chem. 277 2002 18021 18028 (Pubitemid 34967614)